about
Amyloid β oligomers (AβOs) in Alzheimer's disease.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's diseaseErlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's diseaseAdvantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's DiseasePlasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's diseaseGuidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity - a consensus of the Biomarkers Task Force from the WFSBPClinical significance of fluid biomarkers in Alzheimer's Disease
P50
Q47339779-9D7A7851-0307-4CB7-8539-9C5AEBAA2944Q47587631-47C6E45C-704A-4716-812C-E44860017798Q58699109-18ED313F-AC81-4287-85C7-507AA367C1D1Q60920280-7D97A21A-6485-460B-A17E-013454C10720Q64098834-3014E3FB-895F-4529-8883-0130C33A6390Q90588474-7D175604-24B8-427E-BADC-156494F859D3Q92590145-E9E798E9-59CE-49C1-8584-619BC4B93742Q94571511-6E4FF224-AE85-4759-B4B5-7D838C469507
P50
description
researcher, ORCID id # 0000-0002-8101-6535
@en
wetenschapper
@nl
name
Piotr Lewczuk
@ast
Piotr Lewczuk
@en
Piotr Lewczuk
@es
Piotr Lewczuk
@nl
type
label
Piotr Lewczuk
@ast
Piotr Lewczuk
@en
Piotr Lewczuk
@es
Piotr Lewczuk
@nl
altLabel
Lewczuk P
@en
prefLabel
Piotr Lewczuk
@ast
Piotr Lewczuk
@en
Piotr Lewczuk
@es
Piotr Lewczuk
@nl
P106
P21
P31
P496
0000-0002-8101-6535